Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s diseaseChin‐Hsien Lin, Ming‐Shiang Wu, Chieh‐Chang Chen et al.|Journal of Neuroinflammation|2019Cited by 468
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyOwen A. Ross, Hiroyuki Tomiyama, Alexandra I. Soto‐Ortolaza et al.|The Lancet Neurology|2011Cited by 344
Plasma α-synuclein predicts cognitive decline in Parkinson’s diseaseChin‐Hsien Lin, Ming‐Jang Chiu|Journal of Neurology Neurosurgery & Psychiatry|2017Cited by 144
Gut microbiome in Parkinson's disease: New insights from meta-analysisTzi Shin Toh, Ai Huey Tan, Jeff S. Bowman et al.|Parkinsonism & Related Disorders|2021Cited by 132
Mitochondrial <i>UQCRC1</i> mutations cause autosomal dominant parkinsonism with polyneuropathyChin‐Hsien Lin, Ruey‐Meei Wu, Pei-I Tsai et al.|Brain|2020Cited by 77